Devereaux; McGillion
A new PHRI study is part of a Canada-European Union (EU) consortium to develop, test and support novel e-health solutions that enable “ageing-in-place,” defined as helping older people and their caregivers self- or co-manage their health condition(s) and adapt to their changing circumstances, needs and preferences.
VISION-2 study co-Principal Investigators Michael McGillion and PJ Devereaux and their team are using an innovative continuous vital signs monitoring wearable device to measure heart rate, breathing rate, oxygen saturation and blood pressure, with an earbud-sensor to measure core body temperature.
The purpose of the study is to determine what and how happens before a person’s heart muscle is damaged by insufficient blood or oxygen flow, an incident known medically as myocardial injury after non-cardiac surgery.
Other projects within the European-Canadian consortium – involving Norway, Denmark, and The Netherlands as well – called Smart Inclusive Living Environments (SMILE), include:
- Artificial Intelligence-based integration systems known as a “digital care facilitators.”
- Conversational agents as everyday intermediaries between the older person, family, friends and other members of their circles of care.
- Various personal mHealth apps, monitors and devices.
Aside from the VISION-2 study, a team of PHRI researchers, led by Michael McGillion, recently published their validation of a continuous non-invasive remote automated blood pressure monitoring with novel wearable technology – as profiled in the SMILE news section.
